Search clinical trials for: Antipsychotic Agents

Total 188577 results

Tianjin Anding Hospital

Recruiting

Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder

Healthy | Anxiety Disorder

China
Northwell Health
National Institutes of Health (NIH)

Withdrawn

Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

Bipolar I Disorder

United States
Washington University School of Medicine
AssureRx Health, Inc.

Terminated

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Depressive Disorder | Depression | Major Depressive Disorder | Depression, Unipolar | Depressive Episode

United States
FORUM Pharmaceuticals Inc

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Central Nervous System Diseases | Schizophrenia | Schizoaffective Disorder

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (PsiProsper)

Schizophrenia

Portugal
Duke University
Janssen, LP

Terminated

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

Schizophrenia

United States
US Department of Veterans Affairs

Completed

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Schizophrenia | Bipolar Disorder | Autistic Disorder | Conduct and Other Disruptive Behavior Disorders

United States, Belgium, Germany, Poland, Greece, Netherlands
Beth Israel Deaconess Medical Center
Dartmouth-Hitchcock Medical Center

Active, not recruiting

Treating Schizophrenia by Correcting Abnormal Brain Development

Schizophrenia

United States
Central South University
China Medical University, China; Xiangya Hospital of Central South University; Sun Yat-sen University and other collaborators

Completed

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Schizophrenia | Metabolic Syndrome

China
Dartmouth-Hitchcock Medical Center
Harvard Medical School (HMS and HSDM); National Institute on Alcohol Abuse... and other collaborators

Terminated

Alcoholism and Schizophrenia: Effects of Clozapine

Schizophrenia | Schizoaffective Disorder | Substance Abuse | Dual Diagnosis | Alcohol Abuse | Psychotic Disorder

United States
Janssen-Ortho Inc., Canada

Terminated

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Schizophrenia

Canada, United Kingdom, Australia, Ireland
Janssen-Ortho Inc., Canada

Completed

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
University of Alabama at Birmingham

Recruiting

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

Psychosis

United States
University of Massachusetts, Worcester
Massachusetts General Hospital; University of North Carolina, Chapel Hill; Augusta... and other collaborators

Completed

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Schizophrenia | Schizoaffective Disorder | Substance Use Disorders

United States
Dr. Martin A. Katzman

Recruiting

Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Canada
AbbVie

Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Depression | Mania | Bipolar I Disorder

United States, Bulgaria, Korea, Republic of, Malaysia, Poland, Puerto Rico, Russian Federation, Serbia, Taiwan, Thailand, Ukraine
AbbVie

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Bulgaria, Estonia, Germany, Hungary, Ukraine, United Kingdom
Organon and Co

Completed

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Psychosis
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
H. Lundbeck A/S

Completed

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Schizophrenia

France
University Hospitals Cleveland Medical Center
Case Western Reserve University

Completed

Asenapine in the Treatment of Older Adults With Bipolar Disorder

Bipolar Disorder

United States
Novartis Pharmaceuticals

Completed

Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers

Hepatic Impairment

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Amsterdam UMC, location VUmc

Completed

Haloperidol Prophylaxis in Older Emergency Department Patients (HARPOON)

Delirium

Netherlands
Central South University

Recruiting

A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia

Schizophrenia

China
Organon and Co

Completed

Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)

Schizophrenia
Supernus Pharmaceuticals, Inc.

Completed

Open-Label, Extension Study to 810P202

Impulsive Aggression Comorbid With ADHD in Children

United States
Maurizio Fava, MD
Novartis Pharmaceuticals

Completed

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Major Depressive Disorder

United States
Vanda Pharmaceuticals

Completed

A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia

Schizophrenia

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Mania

Bipolar Disorder | Mania

United States, India
Northwestern University
Novartis Pharmaceuticals

Terminated

Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Centre de Recherche de l'Institut Universitaire...

Unknown

Investigator Initiated Study - Asenapine Early Psychosis

Disorders | Schizophrenia and Disorders With Psychotic Features

Canada
New York State Psychiatric Institute

Not yet recruiting

Dopamine D3 Receptor Occupancy in Bipolar Depression

Bipolar Depression

United States
AstraZeneca

Completed

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Schizophrenia

United States
Dalian Seventh People's Hospital
TAKARA BIOTECHNOLOGY(DALIAN)CO.,LTD.

Unknown

The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients

Schizophrenia | Micrognathia

China
University of Cincinnati
AstraZeneca

Completed

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

Bipolar I Disorder

United States
RWTH Aachen University

Completed

Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology

Bipolar Disorder

Germany
New Mexico VA Healthcare System
AstraZeneca

Completed

Schizophrenia Sensory Gating Deficit With Quetiapine

Schizophrenia

United States
Arthur P. Noyes Research Foundation

Unknown

Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

Smoking Behavior in Schizophrenia

United States
Deborah Yurgelun-Todd
Otsuka America Pharmaceutical

Completed

Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism

Schizophrenia

United States
Beersheva Mental Health Center
Tirat Carmel Mental Health Center

Completed

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Chronic Schizophrenia

Israel
AstraZeneca

Completed

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Bipolar Disorder

United States, Canada
Sun Pharmaceutical Industries Limited
bioRASI, LLC

Completed

Bio-equivalence Study Between SAPHRIS and Asenapine (ASN)

Schizophrenia | Bipolar Disorder

United States
Forest Laboratories

Completed

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Depression | Bipolar Disorder

United States, Bulgaria, Serbia, Ukraine, Croatia, Romania, Puerto Rico, Slovakia
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Bipolar Depression

United States
Vanda Pharmaceuticals

Recruiting

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Schizophrenia | Bipolar I Disorder

United States
AbbVie

Active, not recruiting

Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia

Schizophrenia

Japan, Taiwan
AbbVie

Terminated

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Schizophrenia

United States, Serbia, Korea, Republic of, Malaysia, Poland, Bulgaria, Ukraine, Puerto Rico, Romania, Taiwan, Thailand
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine

Search clinical trials for: Antipsychotic Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations